Blood group abh‐related antigens in normal and malignant bladder urothelium: Possible structural basis for the deletion of type‐2 chain abh antigens in invasive carcinomas

International Journal of Cancer

Volumn 43, Issue 5, 1989, Pages 774-780

  Ørntoft, Torben F ^a   Wolf, Hans ^b   Clausen, Henrik ^c,d   Dabelsteen, Erik ^c   Hakomori, Sen‐Itiroh ^d  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

BLADDER CARCINOMA; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, MONOCLONAL; BLADDER; BLADDER NEOPLASMS; CARBOHYDRATE SEQUENCE; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME DELETION; EPITHELIUM; FEMALE; GENES, STRUCTURAL; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; REFERENCE VALUES; RH-HR BLOOD-GROUP SYSTEM; SUPPORT, NON-U.S. GOV'T;

EID: 0024394754     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910430505     Document Type: Article

References (41)

1. y) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinomas
2. The monoclonal antibody directed to difucosylated Type 2 chain ‘fucα1‐2Galβ1‐4(fucα1‐3) GlcNAc’; Y determinant
3. Classification of bladder tumors based on the cellular pattern
4. Blood group antigens and bladder cancer
5. Immunohistochemical localization of Y hapten and the structurally related H type‐2 blood‐Group antigen on large‐Bowel tumours and normal adult tissues
6. Further characterization of Type 2 and Type 3 chain blood group A glycosphingolipids from human erythrocyte membranes
7. 2 distinction
8. y)
9. 2 distinction
10. Immunoanatomic distribution of blood group antigens in the human urinary tract
11. y determinants in urothelial carcinoma
12. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens
13. Antigen deletion and prognosis of patients with stage A transitional cell bladder carcinoma
14. Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono‐, di‐, and trifucosylated Type 2 chain
15. Localization and alteration of mono‐, di‐, and trifucosyl α1‐3 Type 2 chain structures during human embryogenesis and in human cancer
16. Characterization of sialosylated Lewis x as a new tumor‐Associated antigen
17. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis
18. Blood group ABH and I; antigens of human erythrocytes: chemistry, polymorphism, and their developmental change
19. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives
20. Glycosphingolipids as tumor‐Associated and differentiation markers
21. Cytostructural localization of a tumor‐Associated antigen
22. Lewis a antigen in transitional cell tumors of the urinary bladder
23. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder
24. Quantitative and qualitative characterization of human cancer‐Associated serum glycoprotein antigens expressing fucosyl or sialylfucosyl Type 2 chain polylactosamine
25. A and B antigens of tumors arising from urinary epithelium
26. y blood group‐Related antigens in human malignant, premalignant, and non‐Malignant colonic tissues
27. Monoclonal antibodies specific for Type 3 and Type 4 chain‐Based bloodgroup determinants: relationship to the A1 and A2 subgroups
28. A, B, H‐Antigens in transitional cell tumors of the urinary bladder. Correlation with the clinical course
29. b) and Type 2 (x, Y, H) blood group‐Related antigens in the human pyloric and duodenal mucosae
30. Genetics of ABO, H, Lewis, X, and related antigens
31. Blood group ABO and Lewis antigen expression during neoplastic progression of human urothelium: immunohistochemical study of type 1 chain structures
32. Blood group ABO and Lewis antigens in fetal and normal adult bladder urothelium: immunohistochemical study of Type 1 chain structures
33. Blood group ABO‐Related antigens in fetal and normal adult bladder urothelium: immunohistochemical study of Type 2 chain structures with a panel of mouse monoclonal antibodies
34. Activity of the human blood group ABO, Se, H, Le and X gene‐Encoded glycosyltransferases in normal and malignant bladder urothelium
35. Expression of Lewis a, Lewis b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor‐Derived cell lines
36. Blood group antigens and bladder carcinoma: a perspective
37. Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen‐Friedenreich antigen status and karyotype of the initial tumor
38. The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium
39. Biochemistry and genetics of the ABO, Lewis, and P blood group systems
40. Distribution of blood group antigens A, B, H, Lewis a, and Lewis b in human normal, fetal, and malignant colonic tissue
41. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto‐N‐Glycosyl Type II chain